Elsevier

The Lancet

Volume 347, Issue 9002, 9 March 1996, Pages 649-653
The Lancet

Articles
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

https://doi.org/10.1016/S0140-6736(96)91203-9Get rights and content

Abstract

Summary

Background Metastasis is generally looked on as a late event in the natural history of epithelial tumours. However, the poor prognosis of patients with apparently localised lung cancer indicates that micrometastases occur often before diagnosis of the primary tumour.

Methods At primary surgery, disseminated tumour cells were detected immunocytochemically in bone marrow of 139 patients with non-small-cell lung carcinomas without evidence of distant metastases (pT1-4pN1-2M0). Tumour cells in bone-marrow aspirates were detected with monoclonal antibody CK2 against cytokeratin polypeptide 18. Patients were followed up for a median of 39 months (range 14-52) after surgery. 215 patients without epithelial cancer (ie, with benign epithelial tumours, non-epithelial neoplasms, or inflammatory diseases) acted as controls.

Findings In 83 of 139 (59·7%) patients cytokeratin-positive cells were detected at frequencies of 1 in 100 000 to 1 in 1000000. Even without histopathological involvement of lymph nodes (pN0), tumour cells were found in 38 of 70 (54·3%) patients. 1 positive cell was found in each of 6 out of 215 controls. Surgical manipulation during primary tumour resection did not affect the frequency of these cells. In Cox's regression analyses, the presence of such cells was a significant and independent predictor for a later clinical relapse in node-negative patients (p=0·028).

Interpretation Early dissemination of isolated tumour cells is a frequent and intrinsic characteristic of non-small-cell lung carcinomas. The finding of these cells may help to decide whether adjuvant systemic therapy is required for the individual patient.

References (29)

  • Jl Cordell et al.

    Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes)

    J Histochem Cytochem

    (1984)
  • B. Passlick et al.

    Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer

    J Clin Oncol

    (1994)
  • F. Momburg et al.

    Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues

    Cancer Res

    (1987)
  • U. Latza et al.

    Ber-EP4: new monoclonal antibody which distinguishes epithelial from mesothelia

    J Clin Pathol

    (1990)
  • Cited by (383)

    • Disseminated tumor cells in bone marrow of cancer patients: Biology and clinical relevance

      2021, Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
    • External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non–Small Cell Lung Cancer Patients With N3 Disease

      2017, Clinical Lung Cancer
      Citation Excerpt :

      The same factors were found to be independent prognosticators for DSS (Table 4). The majority of patients with NSCLC present with advanced-stage or metastatic disease, with a significant portion developing distant relapse.9,10 Historically, the 5-year survival rate for those with stage IIIB cancers has been dismal at approximately 5%, and for those with distant metastases even lower.11

    • Cancer stem cells: The root of tumor recurrence and metastases

      2017, Seminars in Cancer Biology
      Citation Excerpt :

      The steady state that regulates dormancy might be disturbed by both changes in DTC (for example, additional mutations or epigenetic modifications in genes controlling cell proliferation and apoptosis) and the surrounding microenvironment [123]. Cancer cells in patients with breast, lung and prostate cancer disseminate early into the bone marrow and pose a risk for subsequent relapse [132–134]. Despite the common belief that tumor cell “shedding” is a passive random process, there is evidence for an expression signature related to the presence of CTC/DTC [135,136].

    • Chapter 115A - Liver transplantation for hepatocellular carcinoma

      2016, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition
    View all citing articles on Scopus
    View full text